Literature DB >> 23343697

Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.

Haider K Bangash1, Tunisia Finch, Vesna Petronic-Rosic, Aisha Sethi, Emily Abramsohn, Stacy Tessler Lindau.   

Abstract

BACKGROUND: Nortriptyline and other tricyclic antidepressants are widely used in the treatment of depression. They are also used in chronic pain syndromes such as vulvodynia. We report a case of pityriasis rosea (PR)-like eruption in a young woman who was treated with oral nortriptyline for vulvodynia. CASE REPORT: The patient presented with photosensitivity and erythematous, well-defined, oval papules and patches, with fine collarettes of scale on the dorsal hands, upper arms, and trunk. She showed a complete resolution of her rash with discontinuation of nortriptyline, thereby supporting the diagnosis of a drug-induced reaction. COMMENT: Pityriasis rosea-like drug eruptions have been associated with numerous medications, including angiotensin-converting enzyme inhibitors, antirheumatic drugs, lithium, and, more recently, biologics such as imatinib, adalimumab, and etanercept. A literature review did not reveal an association between PR-like drug eruptions and tricyclic antidepressants such as nortriptyline. We report a case of PR-like drug reaction to nortriptyline for clinical interest.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23343697      PMCID: PMC3608714          DOI: 10.1097/LGT.0b013e31825d7c5f

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  14 in total

1.  Pityriasis rosea-like eruption due to ergotamine: a case report.

Authors:  Kenan Aydogan; Serap Koran Karadogan; Saduman Balaban Adim; Sukran Tunali
Journal:  J Dermatol       Date:  2005-05       Impact factor: 4.005

2.  Pityriasis Rosea-Like Eruption due to Lithium.

Authors:  Mustafa Senol; Atilla Ozcan; Erkan M Ozcan; Engin N Aydin
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 3.  Pharmacologic management of neuropathic pain: evidence-based recommendations.

Authors:  Robert H Dworkin; Alec B O'Connor; Miroslav Backonja; John T Farrar; Nanna B Finnerup; Troels S Jensen; Eija A Kalso; John D Loeser; Christine Miaskowski; Turo J Nurmikko; Russell K Portenoy; Andrew S C Rice; Brett R Stacey; Rolf-Detlef Treede; Dennis C Turk; Mark S Wallace
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

4.  Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial.

Authors:  David C Foster; Merrill Beth Kotok; Li-Shan Huang; Arthur Watts; David Oakes; Fred M Howard; Ellen L Poleshuck; Chris J Stodgell; Robert H Dworkin
Journal:  Obstet Gynecol       Date:  2010-09       Impact factor: 7.661

5.  Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption.

Authors:  F De Keyser; J M Naeyaert; P Hindryckx; D Elewaut; P Verplancke; I Peene; M Praet; E Veys
Journal:  Clin Exp Rheumatol       Date:  2000 Jan-Feb       Impact factor: 4.473

6.  Pityriasis rosea-like eruption due to bismuth.

Authors:  N Michelle Hanjani; Adrienne Rencic; S Elizabeth Whitmore
Journal:  Cutis       Date:  2006-03

7.  Pityriasis rosea during etanercept therapy.

Authors:  C Guarneri; G Polimeni; G Nunnari
Journal:  Eur Rev Med Pharmacol Sci       Date:  2009 Sep-Oct       Impact factor: 3.507

Review 8.  Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology.

Authors:  Francesco Drago; Francesco Broccolo; Alfredo Rebora
Journal:  J Am Acad Dermatol       Date:  2009-08       Impact factor: 11.527

9.  Pityriasis rosea-like eruption due to pneumococcal vaccine in a child with nephrotic syndrome.

Authors:  Sezai Sasmaz; Hamza Karabiber; Cetin Boran; Mesut Garipardic; Ayse Balat
Journal:  J Dermatol       Date:  2003-03       Impact factor: 4.005

Review 10.  New concepts in vulvodynia.

Authors:  Libby Edwards
Journal:  Am J Obstet Gynecol       Date:  2003-09       Impact factor: 8.661

View more
  2 in total

1.  In vitro effects of caffeic acid, nortriptyline, precocene I and quercetin against Rhipicephalus annulatus (Acari: Ixodidae).

Authors:  Reghu Ravindran; Nayikottummal Devadas Chithra; Pattanur Edathil Deepa; Karapparambu Gopalan Ajithkumar; Leena Chandrasekhar; Kanapadinchareveetil Sreelekha; Suresh Narayanan Nair; Sanis Juliet; Srikanta Ghosh
Journal:  Exp Appl Acarol       Date:  2017-01-21       Impact factor: 2.132

2.  Evaluation of clinico-epidemiological and histopathological features of pityriasis rosea.

Authors:  Gaye Devrim Ozyürek; Sevil Alan; Erol Cenesizoğlu
Journal:  Postepy Dermatol Alergol       Date:  2014-09-08       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.